K. Okada

K. Okada, O. Matsuo, M. Yano, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The absence of uPAR is associated with the progression of dermal fibrosis.

K. Takeuchi, K. Okada, O. Matsuo, 2008, The Journal of investigative dermatology.

Lack of α2-Antiplasmin Enhances ADP Induced Platelet Micro-Aggregation through the Presence of Excess Active Plasmin in Mice

O. Kozawa, K. Okada, O. Matsuo, 2002, Journal of Thrombosis and Thrombolysis.

α2‐Antiplasmin is involved in the production of transforming growth factor β1 and fibrosis

K. Okada, O. Matsuo, H. Matsuno, 2007 .

Monoclonal antibody enhances plasminogen activation by t-PA.

K. Okada, O. Matsuo, S. Ueshima, 1989, Thrombosis research.

Monoclonal antibody interferes with fibrin binding of t-PA.

K. Okada, O. Matsuo, S. Ueshima, 1988, Thrombosis research.

Thrombolytic effect of pro-plasminogen activator in a rabbit jugular vein thrombosis model

H. Bando, K. Okada, O. Matsuo, 1986 .

Biochemical characteristics and fibrinolytic activity of pro-plasminogen activator

H. Bando, K. Okada, O. Matsuo, 1986 .

MicroRNA-196a-5p in Extracellular Vesicles Secreted from Myoblasts Suppresses Osteoclast-like Cell Formation in Mouse Cells

M. Muratani, K. Okada, N. Kawao, 2020, Calcified Tissue International.

Comparative Fibrinolytic Properties of Staphylokinase and Streptokinase in Animal Models of Venous Thrombosis

K. Okada, O. Matsuo, D. Collen, 1991, Thrombosis and Haemostasis.

Binding of plasminogen to hepatocytes isolated from injured mice liver and nonparenchymal cell-dependent proliferation of hepatocytes

K. Okada, O. Matsuo, T. Ariga, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The regulation of liver regeneration by the plasmin/α2-antiplasmin system

K. Okada, O. Matsuo, M. Imano, 2004 .

Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice

P. Carmeliet, K. Okada, O. Matsuo, 2001 .

Inhibiotory effect of monensin on secretion of tissue plasminogen activator

H. Bando, K. Okada, O. Matsuo, 1985 .

Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production.

M. Hatano, M. Arima, T. Tokuhisa, 2013, Life sciences.

Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.

K. Okada, O. Matsuo, S. Ueshima, 2004, Thrombosis research.

Thrombolytic effect of pro-urokinase in vitro

H. Bando, K. Okada, O. Matsuo, 1987 .

Enhancement of fibrinolytic activity in vascular endothelial cells by heterologous expression of adenine nucleotide translocase-1

N. Nagai, K. Okada, O. Matsuo, 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Stabilization of plasmin by lysine derivatives.

K. Okada, O. Matsuo, S. Ueshima, 1996, Clinica chimica acta; international journal of clinical chemistry.

Tissue‐type plasminogen activator and its inhibitor in human glomerulonephritis

K. Okada, O. Matsuo, K. Yoshioka, 1992, The Journal of pathology.

Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia.

T. Ohmori, Y. Kashiwakura, A. Ishiwata, 2008, Thrombosis research.

Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.

K. Okada, O. Matsuo, T. Matsuo, 1992, Thrombosis research.

Fibrodysplasia Ossificans Progressiva-related Activated Activin-like Kinase Signaling Enhances Osteoclast Formation during Heterotopic Ossification in Muscle Tissues*

K. Okada, M. Yano, N. Kawao, 2014, The Journal of Biological Chemistry.

Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model

K. Oiwa, Y. Okada, K. Okada, 2003, Thrombosis and Haemostasis.

Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.

K. Okada, O. Matsuo, S. Ueshima, 1990, Thrombosis research. Supplement.

FIBRINOLYTIC ACTIVITY IN LIVER TISSUES OF STROKE‐PRONE SPONTANEOUSLY HYPERTENSIVE RATS

K. Okada, O. Matsuo, S. Ueshima, 1995, Clinical and experimental pharmacology & physiology. Supplement.

Effects of α2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex

K. Okada, O. Matsuo, S. Ueshima, 1994 .

Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.

K. Okada, O. Matsuo, S. Ueshima, 1994, Thrombosis research.

Plasminogen activator in bronchoalveolar fluid.

H. Bando, K. Okada, O. Matsuo, 1986, Haemostasis.

Plasminogen-Dependent Collagenolytic Properties of Staphylococcus aureus in Collagen Gel Cultures of Human Corneal Fibroblasts.

K. Sugioka, T. Nishida, Y. Shimomura, 2018, Investigative ophthalmology & visual science.

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report

K. Sugioka, Y. Shimomura, K. Okada, 2012, BMC Ophthalmology.

The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide.

K. Sugioka, Y. Shimomura, K. Okada, 2014, Investigative ophthalmology & visual science.

TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.

K. Sugioka, C. Matsumoto, Y. Shimomura, 2013, Experimental eye research.

Urokinase-type plasminogen activator (uPA) negatively regulates α-smooth muscle actin expression via Endo180 and the uPA receptor in corneal fibroblasts.

T. Nishida, K. Okada, S. Kusaka, 2022, American journal of physiology. Cell physiology.

Purification and characterization of the plasminogen activator from bladder tumors

H. Bando, K. Okada, O. Matsuo, 1986 .

Thrombolytic effect of single-chain pro-urokinase in a rabbit jugular vein thrombosis model.

H. Bando, K. Okada, O. Matsuo, 1986, Thrombosis research.

Effect of monensin on secretion of t-PA from melanoma (Bowes).

K. Okada, O. Matsuo, S. Ueshima, 1989, Cell structure and function.

Monoclonal antibody to human tissue plasminogen activator.

H. Bando, K. Okada, O. Matsuo, 1984, Thrombosis research.

Expression in E. coli of finger‐domain lacking tissue‐type plasminogen activator with high fibrin affinity

H Bando, H. Bando, K. Okada, 1985, FEBS letters.

Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice

N. Nagai, K. Okada, O. Matsuo, 2011, Thrombosis and Haemostasis.

Initial brain lesion size affects the extent of subsequent pathophysiological responses

N. Nagai, K. Okada, O. Matsuo, 2010, Brain Research.

The absence of uPAR attenuates insulin-induced vascular smooth muscle cell migration and proliferation.

K. Takeuchi, K. Okada, O. Matsuo, 2008, Thrombosis research.

α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice.

M. Akagi, K. Okada, O. Matsuo, 2015, Bone.

Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast Function*

A. Ishisaki, T. Nishihara, K. Toyoshima, 2011, The Journal of Biological Chemistry.

Alpha2-antiplasmin is involved in the production of transforming growth factor beta1 and fibrosis.

K. Okada, O. Matsuo, H. Matsuno, 2007, Journal of thrombosis and haemostasis : JTH.

Leukocyte Tissue-Type Plasminogen Activator Activity in Dialysis Patients

K. Okada, O. Matsuo, K. Mori, 1989, The International journal of artificial organs.

Lack of 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice

Kiyotaka Okada, Osamu Matsuo, Keiichi Nakajima, 2003 .

Cerebral Plasminogen Activator Activity in Spontaneously Hypertensive Stroke‐Prone Rats

K. Okada, K. Okada, O. Matsuo, 1992, Stroke.

Cellular density regulation of plasminogen gene expression in mouse hepatocytes.

K. Okada, O. Matsuo, T. Seki, 2003, Life sciences.

Fibrinolytic system in the process of wound healing in rat

K. Okada, O. Matsuo, S. Ueshima, 2000 .

Effect of Heat Shock on the Expression of Urokinase-Type Plasminogen Activator Receptor in Human Umbilical Vein Endothelial Cells

K. Okada, O. Matsuo, S. Ueshima, 1996, Thrombosis and Haemostasis.

Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.

K. Okada, O. Matsuo, S. Ueshima, 1990, Thrombosis research. Supplement.

Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water.

K. Okada, O. Matsuo, S. Ueshima, 2003, Pathophysiology : the official journal of the International Society for Pathophysiology.

Incorrect Concentration of α2‐Antiplasmin Shown in Figures in the Article by Kanno et al (Arthritis Rheum, February 2013)

K. Okada, O. Matsuo, H. Matsuno, 2014 .

Biocompatible Block Copolymers Composed of Polydimethylsiloxane and Poly[(2-methacryloyloxy)ethyl phosphorylcholine] Segments

K. Okada, O. Matsuo, K. Sugiyama, 1999 .

Grafting of vinyl monomers on the surface of a poly(ethylene terephthalate) film using Ar plasma‐post polymerization technique to increase biocompatibility

K. Okada, O. Matsuo, K. Sugiyama, 1998 .

Surface Modified Poly(methyl methacrylate) Microspheres with the O-Methacryloyl-L-serine Moiety

K. Okada, O. Matsuo, K. Sugiyama, 1997 .

Plasminogen Activator Inhibitor in Stomach and Colorectal Carcinomas

M. Yasutomi, K. Okada, O. Matsuo, 1991, Seminars in thrombosis and hemostasis.

Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus

N. Nagai, S. Morita, S. Miyata, 2011, Cell and Tissue Research.

Function of Tissue-type Plasminogen Activator Releaser on Vascular Endothelial Cells and Thrombolysis In Vivo

M. Hayashi, K. Okada, O. Matsuo, 2002, Thrombosis and Haemostasis.

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions between positions 37 and 42

K. Okada, O. Matsuo, S. Ueshima, 1994 .

Effect of staphylokinase-derived nonadecapeptide on the activation of plasminogen

K. Okada, O. Matsuo, H. Matsuno, 2007, Thrombosis and Haemostasis.

Role of plasminogen in macrophage accumulation during liver repair.

N. Nagai, K. Okada, O. Matsuo, 2010, Thrombosis research.

Studies on plasminogen activator produced by the cultured cell line from the tissue of human ovary

H. Bando, K. Okada, O. Matsuo, 1987 .

Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice

M. Akagi, K. Okada, O. Matsuo, 2017, BMC Musculoskeletal Disorders.

Platelet aggregation induced by cryoprecipitate infusion in platelet-type von Willebrand's disease.

S. Abe, K. Okada, A. Shibata, 1987, Thrombosis research.

Tissue plasminogen activator and plasminogen are critical for osmotic homeostasis by regulating vasopressin secretion

Y. Nakatani, S. Morita, S. Miyata, 2010, Journal of neuroscience research.

Matrix vesicles promote bone repair after a femoral bone defect in mice

Y. Tabata, J. Jo, K. Okada, 2023, PloS one.

The regulation of liver regeneration by the plasmin/alpha 2-antiplasmin system.

K. Okada, O. Matsuo, M. Imano, 2004, Journal of hepatology.

Involvement of α2‐antiplasmin in dendritic growth of hippocampal neurons

K. Okada, O. Matsuo, H. Matsuno, 2013, Journal of neurochemistry.

Effects of fibrin and α2‐antiplasmin on plasminogen activation by staphylokinase

K. Okada, O. Matsuo, S. Ueshima, 1996, American journal of hematology.

Tumor Necrosis Factor-α Blunts the Osteogenic Effects of Muscle Cell-Derived Extracellular Vesicles by Affecting Muscle Cells

T. Ohira, K. Okada, Yuya Mizukami, 2022, Calcified Tissue International.

Extracellular vesicles secreted from mouse muscle cells suppress osteoclast formation: Roles of mitochondrial energy metabolism.

K. Okada, N. Kawao, H. Kaji, 2020, Bone.

Effect of sodium ozagrel on platelet rich plasma clot lysis

K. Okada, O. Matsuo, S. Ueshima, 1997 .

Determination of a factor VIII-interactive region within plasmin responsible for plasmin-catalysed activation and inactivation of factor VIII(a)

K. Nogami, M. Shima, K. Okada, 2010, Thrombosis and Haemostasis.

Procoagulant Properties of Intravenous Staphylokinase Versus Tissue-Type Plasminogen Activator

H. Moreau, K. Okada, D. Collen, 1996, Thrombosis and Haemostasis.

Plasminogen activator in bladder tumors

H. Bando, K. Okada, O. Matsuo, 2004, Urological Research.

Regulation of scu-PA secretion and u-PA receptor expression in osteoblast-like cells.

K. Okada, O. Matsuo, S. Ueshima, 1993, Cell structure and function.

Intracellular distribution of tissue-type plasminogen activator in human melanoma cells.

H. Bando, K. Okada, O. Matsuo, 1988 .

The Structure and Function of Staphylokinase

K. Okada, O. Matsuo, 2000 .

Effects of extracellular ATP and Ca2+ ion on the secretion of tissue-type plasminogen activator from cultured human melanoma cells (Bowes)

H. Bando, K. Okada, O. Matsuo, 1986 .

A Novel Factor, Tmem176b, Induced by Activin-like Kinase 2 Signal Promotes the Differentiation of Myoblasts into Osteoblasts

K. Okada, M. Yano, N. Kawao, 2013, Experimental and clinical endocrinology & diabetes.

Effect of bone resorbing factors on u-PA and its specific receptor in osteosarcoma cell line.

K. Okada, O. Matsuo, S. Ueshima, 1993, Clinica chimica acta; international journal of clinical chemistry.

Lack of α2‐antiplasmin improves cutaneous wound healing via over‐released vascular endothelial growth factor‐induced angiogenesis in wound lesions

A. Ishisaki, K. Matsushita, K. Okada, 2006, Journal of thrombosis and haemostasis : JTH.

Role of plasminogen activator inhibitor-1 in muscle wasting induced by a diabetic state in female mice.

K. Okada, O. Matsuo, Yuya Mizukami, 2021, Endocrine journal.

Involvement of plasminogen activator inhibitor-1 in the pathogenesis of atopic cataracts.

A. Murakami, K. Mori, Kojiro Imai, 2012, Investigative ophthalmology & visual science.

Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.

O. Kozawa, K. Okada, O. Matsuo, 2003, Journal of thrombosis and haemostasis : JTH.

Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.

K. Okada, O. Matsuo, M. Yano, 2014, American journal of physiology. Endocrinology and metabolism.

Role of Plasminogen Activator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice

K. Okada, N. Kawao, K. Okumoto, 2014, Diabetes.

c-Myc is essential for urokinase plasminogen activator expression on hypoxia-induced vascular smooth muscle cells.

K. Okada, O. Matsuo, S. Ueshima, 2007, Cardiovascular research.

Physiochemical study on plasminogen and its fragments digested by elastase

H. Bando, K. Okada, O. Matsuo, 1986 .

Lack of 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice

A. Ishisaki, K. Okada, H. Matsuno, 2003 .

Plasminogen activator inhibitor-1 is involved in glucocorticoid-induced decreases in angiogenesis during bone repair in mice.

K. Okada, Yuya Mizukami, N. Kawao, 2024, Journal of bone and mineral metabolism.